Abstract:Cancer classification plays an important role in cancer treatment. There has been no general approach for this problem now. The tasks for cancer classification are of two aspects: identifying new cancer classes and assigning tumors to known classes, which are called class discovery and class prediction by Golub et al. [1]. From mathematical point of view, class discovery is a cluster analysis problem, while class prediction is usually called classification problem (we’ll use the later name to keep consist with pattern recognition literatures). Until now, cancer classification has been based primarily on morphological appearance of tumor [1]. This has serious limitations because of ambiguity. Golub et al. presented a new approach to cancer classification based on gene expression monitoring by DNA microarrays in [1]. They chose acute leukemia as a test case, and the target is to distinguish between ALL (acute lymphoblastic leukemia) and AML (acute myeloid leukemia), which is a typical cancer classification problem not well solved despite many years of efforts. This paper is a report of our work on the classification (prediction) part of this problem following their original work. Golub et al. adopted a feature selection (gene selection) procedure before classification. A metric was defined to evaluate the correlation of each gene to the classification. After some “good” genes were selected from all the 6817 genes, the classification is done by a weighted voting scheme. The classifier was trained on a 38-sample training set, and another 34-sample set was used for testing. With leave-one-out cross-validation on the training set with 50 selected genes, 36 out of 38 samples were correctly classified and 2 were rejected (no-call). The performance on the test set was that 29 samples out of 34 were correctly classified and the other 5 were rejected. If the classifier were compelled to give these 5 no-calls a prediction, the prediction would be wrong. Since the feature selection procedure is of single selection type, and the classification method is also an intuitive one, we believe that there is still much space for the performance to be improved. In our approach to the problem, we took all the genes for the classification (the selection problem will be discussed in another paper), and applied the support vector machine(SVM) method and one of its improved version CSVM as the classifier. Thanks to the better generalization ability of SVM and CSVM, much better performance was obtained.

Classification Of Diffuse Large B Cell Lymphoma Gene Expression Data Based On Two-Layer Particle Swarm Optimization

Cancer Classification Based on Support Vector Machine Optimized by Particle Swarm Optimization and Artificial Bee Colony

Machine learning‐based classification of diffuse large B‐cell lymphoma patients by eight gene expression profiles

Research on Text Classification Method of LDA- SVM Based on PSO optimization

A gene selection algorithm for microarray cancer classification using an improved particle swarm optimization

A Cancer Gene Clustering Algorithm based on Quantum-behaved Particle Swarm with Comprehensive Learning Strategy

ICGA-PSO-ELM Approach for Accurate Multiclass Cancer Classification Resulting in Reduced Gene Sets in Which Genes Encoding Secreted Proteins Are Highly Represented

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Classification of cancer types based on microRNA expression using a hybrid radial basis function and particle swarm optimization algorithm

ALL/AML Cancer Classification by Gene Expression Data Using SVM and CSVM Approach

A study on breast cancer image classification based on particle swarm algorithm and transfer learning

Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma Using RNA-Seq Data

Investigation on particle swarm optimisation for feature selection on high-dimensional data: local search and selection bias

Gene selection from microarray expression data: A Multi-objective PSO with adaptive K-nearest neighborhood

Artificial Intelligence Analysis and Reverse Engineering of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using Gene Expression Data

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Feature Selection Using Enhanced Particle Swarm Optimisation for Classification Models

Deep learning-based classifier of diffuse large B-cell lymphoma cell-of-origin with clinical outcome

Deep learning approach for brain tumor classification using metaheuristic optimization with gene expression data